Health Care Costs

Costo efectividad de la vacunación contra influenza en menores de 2 años y mayores de 65 años en Colombia

Economics / Colombia / Cancer / Australia / Quality of life / Risk / Forecasting / Argentina / Treatment Outcome / Decision Analysis / Health Policy / Pharmacoeconomics / Adolescent / Prevention / Israel / Biological Sciences / Decision Trees / Humans / Child / Age / Pneumonia / Young Adult / Infant / Vaccine / Cost effectiveness / Life Expectancy / Incidence / Vaccination / Discount Rate / Risk factors / Newborn Infant / Aged / Middle Aged / Quality adjusted life years / Adult / Economic Models / Cost Benefit Analysis / Retrospective Studies / Age Factors / Economic evaluation / Influenza Vaccine / Risk Factors / Vaccine Effectiveness / Older Adult / Cost of Illness / Health Care Costs / Age Groups / Nino / Immunization Programs / Child preschool / Risk / Forecasting / Argentina / Treatment Outcome / Decision Analysis / Health Policy / Pharmacoeconomics / Adolescent / Prevention / Israel / Biological Sciences / Decision Trees / Humans / Child / Age / Pneumonia / Young Adult / Infant / Vaccine / Cost effectiveness / Life Expectancy / Incidence / Vaccination / Discount Rate / Risk factors / Newborn Infant / Aged / Middle Aged / Quality adjusted life years / Adult / Economic Models / Cost Benefit Analysis / Retrospective Studies / Age Factors / Economic evaluation / Influenza Vaccine / Risk Factors / Vaccine Effectiveness / Older Adult / Cost of Illness / Health Care Costs / Age Groups / Nino / Immunization Programs / Child preschool

ESTRATEGIAS GRUPALES

Immunology / Decision Making / Hospitals / Spain / Clinical Practice / Humans / Data Collection / Health Professionals / Immunoglobulin E / Immunochemistry / Spirometry / Functional Group / Health Care Costs / Hypersensitivity / Allergy and Immunology / Costs and Cost Analysis / Humans / Data Collection / Health Professionals / Immunoglobulin E / Immunochemistry / Spirometry / Functional Group / Health Care Costs / Hypersensitivity / Allergy and Immunology / Costs and Cost Analysis

El costo de la atención médica del cáncer mamario: el caso del Instituto Mexicano del Seguro Social

Social Security / Mexico / Humans / Female / Public health systems and services research / MEXICO / Health Care Costs / MEXICO / Health Care Costs

El costo de la atención médica del cáncer mamario: el caso del Instituto Mexicano del Seguro Social

Social Security / Mexico / Humans / Female / Public health systems and services research / MEXICO / Health Care Costs / MEXICO / Health Care Costs

Veno-arterial extracorporeal membrane oxygenation using Levitronix centrifugal pump as bridge to decision for refractory cardiogenic shock

Nursing / Cardiology / Treatment Outcome / Critical Care / Critical Care Medicine / Electrocardiography / Canada / Hypothermia / Humans / CS / Left Ventricular Assist Device / Female / Resuscitation / Male / Lung Diseases / Act / Refractory / Anesthesia / Perfusion / Clinical Sciences / Aged / Middle Aged / Adult / Surface Area / Public health systems and services research / Cost Benefit Analysis / Retrospective Studies / Prognosis / Chest / Intensive Care Medicine / Coronary Circulation / Centrifugal Pump / Hospital Mortality / Health Care Costs / Diabetic ketoacidosis / Lactic Acid / Logistic Models / Monte Carlo Method / Oxygenation / Thoracic and cardiovascular surgery / Heart Diseases / Extracorporeal Membrane Oxygenation / Assistive Device / Electrocardiography / Canada / Hypothermia / Humans / CS / Left Ventricular Assist Device / Female / Resuscitation / Male / Lung Diseases / Act / Refractory / Anesthesia / Perfusion / Clinical Sciences / Aged / Middle Aged / Adult / Surface Area / Public health systems and services research / Cost Benefit Analysis / Retrospective Studies / Prognosis / Chest / Intensive Care Medicine / Coronary Circulation / Centrifugal Pump / Hospital Mortality / Health Care Costs / Diabetic ketoacidosis / Lactic Acid / Logistic Models / Monte Carlo Method / Oxygenation / Thoracic and cardiovascular surgery / Heart Diseases / Extracorporeal Membrane Oxygenation / Assistive Device

Comparative Effectiveness Research in Radiology

Radiology / Decision Making / Evidence Based Medicine / Health Policy / Health Care reform / Humans / United States / Clinical Sciences / American Recovery and Reinvestment Act (ARRA) / Comparative Effectiveness Research / Health Care Costs / Humans / United States / Clinical Sciences / American Recovery and Reinvestment Act (ARRA) / Comparative Effectiveness Research / Health Care Costs

TRAMOMTANA (Tratamiento Multidisciplinar de la Obesidad Mórbida: Medicamentos, Terapia de comportamiento, Apoyo Nutricional y Actividad física). De la pregunta a la realidad de un ensayo clínico investigador iniciado (II)

Group Therapy / Bariatric Surgery / Research Design / Clinical Trial / Health Education / Treatment Outcome / Adolescent / Exercise therapy / Medicine / Comorbidity / Spain / Humans / Weight Loss / Behavior Therapy / Female / Male / Young Adult / Behavior change / Aged / Middle Aged / Adult / Patient Care Team / Morbid Obesity / Health Care Costs / National Health System / Nutritional Support / Treatment Outcome / Adolescent / Exercise therapy / Medicine / Comorbidity / Spain / Humans / Weight Loss / Behavior Therapy / Female / Male / Young Adult / Behavior change / Aged / Middle Aged / Adult / Patient Care Team / Morbid Obesity / Health Care Costs / National Health System / Nutritional Support

El costo de la atención médica del cáncer mamario: el caso del Instituto Mexicano del Seguro Social

Social Security / Mexico / Humans / Female / Public health systems and services research / MEXICO / Health Care Costs / MEXICO / Health Care Costs

Costo-Efectividad del Cardiodesfibrilador Implantable en Pacientes con Factores de Riesgo de Muerte Súbita en Argentina

Quality of life / Argentina / Treatment Outcome / Public Health / Risk assessment / Social Security / Applied Economics / Sudden Death / Humans / Markov chains / Cost effectiveness / Risk factors / Public health systems and services research / Economic Models / Cost Benefit Analysis / Private Sector / Sudden Cardiac Death / Health Care Utilization / Risk Factors / Risk Assessment / Implantable defibrillators-cardioverters / Health Care Costs / Social Security / Applied Economics / Sudden Death / Humans / Markov chains / Cost effectiveness / Risk factors / Public health systems and services research / Economic Models / Cost Benefit Analysis / Private Sector / Sudden Cardiac Death / Health Care Utilization / Risk Factors / Risk Assessment / Implantable defibrillators-cardioverters / Health Care Costs

Number of oral contraceptive pill packages dispensed and subsequent unintended pregnancies

Obstetrics / Research Methodology / Contraception / Fertility / Population Dynamics / Adolescent / California / Pregnancy / Population / Humans / Child / Female / Obstetrics Gynecology / Young Adult / Data Collection / Clinical Sciences / Developed Countries / Gynecology / Adult / Public health systems and services research / Pregnancy Tests / Health Care Costs / Gestation / Pregnancy Rate / Logistic Models / Adolescent / California / Pregnancy / Population / Humans / Child / Female / Obstetrics Gynecology / Young Adult / Data Collection / Clinical Sciences / Developed Countries / Gynecology / Adult / Public health systems and services research / Pregnancy Tests / Health Care Costs / Gestation / Pregnancy Rate / Logistic Models

Efficience de differentes strategies de detection de la Trypanosomiase Humaine Africaine aT. b. gambiense

Tropical Medicine / Tropical medicine (Health Sciences) / Humans / Animals / Palpation / Public health systems and services research / Cost Benefit Analysis / Sensitivity and Specificity / Health Care Costs / Democratic Republic of the Congo / Lymph nodes / Public health systems and services research / Cost Benefit Analysis / Sensitivity and Specificity / Health Care Costs / Democratic Republic of the Congo / Lymph nodes

Type 2 diabetes mellitus in China: a preventable economic burden

China / Public Health / Humans / Female / Male / Aged / Middle Aged / Health Expenditures / Adult / Public health systems and services research / Cost Benefit Analysis / Health surveys / Health Care Costs / Type 2 Diabetes Mellitus / Cross Sectional Studies / The American / Aged / Middle Aged / Health Expenditures / Adult / Public health systems and services research / Cost Benefit Analysis / Health surveys / Health Care Costs / Type 2 Diabetes Mellitus / Cross Sectional Studies / The American

Practical Guidelines for Economic Evaluations Alongside Equivalence Trials

Research Methodology / Treatment Outcome / Adolescent / Applied Economics / Humans / Cost Effectiveness Analysis / Depressive Disorder / Cost effectiveness / Middle Aged / Quality adjusted life years / Adult / Public health systems and services research / Economic Models / Cost Benefit Analysis / Economic evaluation / Health Care Costs / Cost Effectiveness Analysis / Depressive Disorder / Cost effectiveness / Middle Aged / Quality adjusted life years / Adult / Public health systems and services research / Economic Models / Cost Benefit Analysis / Economic evaluation / Health Care Costs

Femtosecond laser capsulotomy

Femtosecond Laser / Optical coherence tomography / Humans / Female / Animals / Male / Cataract / Clinical Sciences / Aged / Middle Aged / Optometry and Ophthalmology / Swine / Laser Therapy / Phacoemulsification / Health Care Costs / Male / Cataract / Clinical Sciences / Aged / Middle Aged / Optometry and Ophthalmology / Swine / Laser Therapy / Phacoemulsification / Health Care Costs

How Much Do Patients\' Preferences Contribute To Resource Use?

Applied Economics / Multivariate Analysis / Resource use / Humans / Human Resources for Health / United States / Female / Male / Medicare / Aged / Public health systems and services research / Health Care Costs / Utilization review / Choice Behavior / Health affairs / United States / Female / Male / Medicare / Aged / Public health systems and services research / Health Care Costs / Utilization review / Choice Behavior / Health affairs

Evaluación económica de rituximab en combinación con fludarabina y ciclofosfamida en comparación con fludarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica

Spain / Humans / Markov chains / Chronic Lymphocytic Leukemia / Cost effectiveness / Quality adjusted life years / Cost Benefit Analysis / Disease Progression / Health Care Costs / Cyclophosphamide / Monte Carlo Method / Quality adjusted life years / Cost Benefit Analysis / Disease Progression / Health Care Costs / Cyclophosphamide / Monte Carlo Method
Copyright © 2017 DATOSPDF Inc.